Looking for a stock that might be in a good position to beat earnings at its next report? Consider Caterpillar Inc. (CAT - Free Report) , a firm in the Manufacturing - Construction and Mining industry, which could be a great candidate for another beat.
This company has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. In fact, in these reports, CAT has beaten estimates by at least 15% in both cases, suggesting it has a nice short-term history of crushing expectations.
Earnings in Focus
Two quarters ago, CAT expected to post earnings of $1.26 per share, while it actually produced earnings of $1.49 per share, a beat of 18.3%. Meanwhile, for the most recent quarter, the company looked to deliver earnings of $1.22 per share, when it actually saw earnings of $1.95 per share instead, representing a 59.8% positive surprise.
Thanks in part to this history, recent estimates have been moving higher for Caterpillar. In fact, the Earnings ESP for CAT is positive, which is a great sign of a coming beat.
After all, the Zacks Earnings ESP compares the most accurate estimate to the broad consensus, looking to find stocks that have seen big revisions as of late, suggesting that analysts have recently become more bullish on the company’s earnings prospects. This is the case for CAT, as the firm currently has a Zacks Earnings ESP of +2.82%, so another beat could be around the corner.
This is particularly true when you consider that CAT has a great Zacks Rank #1 (Strong Buy) which can be a harbinger of outperformance and a signal for a strong earnings profile. You can see the complete list of today’s Zacks #1 Rank stocks here.
When you add this solid Zacks Rank to a positive Earnings ESP, a positive earnings surprise happens nearly 70% of the time, so it seems pretty likely that CAT could see another beat at its next report, especially if recent trends are any guide.
Investor Alert: Breakthroughs Pending
A medical advance is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating substantial revenue, and even more wondrous products are in the pipeline.
Cures for a variety of deadly diseases are in sight, and so are big potential profits for early investors. Zacks names 5 stocks to buy now.
Click here to see them >>